Antibodies Bap1 Antibody Biology Cells Brd4 Antibody Enzymes Equipments Exosomes PCR Pcr Kits Peptides Pkr Antibody Primary Antibodies Rbpj Antibody Vector & Virus Vitronectin Antibody Western Blot
Human genetic basis of coronavirus disease 2019
Coronavirus illness 2019 (COVID-19) attributable to a novel coronavirus, extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in appreciable morbidity and mortality worldwide. COVID-19 incidence, severity, and mortality charges differ tremendously between populations, genders, ABO blood teams, human leukocyte antigen (HLA) genotypes, ethnic teams, and geographic backgrounds.
This extremely heterogeneous SARS-CoV-2 an infection is multifactorial. Host genetic elements similar to variants within the angiotensin-converting enzyme gene (ACE), the angiotensin-converting enzyme 2 gene (ACE2), the transmembrane protease serine 2 gene (TMPRSS2), together with HLA genotype, and ABO blood group assist to clarify particular person susceptibility, severity, and outcomes of COVID-19.
This assessment is concentrated on COVID-19 medical and viral traits, pathogenesis, and genetic findings, with specific consideration on genetic range and variants. The human genetic foundation may present scientific bases for illness prediction and focused remedy to deal with the COVID-19 scourge.
The Function of the European Society of Human Genetics in Delivering Genomic Training
The European Society of Human Genetics (ESHG) was based in 1967 as knowledgeable organisation for members working in genetics in medical observe, analysis and training. The Society seeks the mixing of scientific analysis and its implementation into medical observe and the training of specialists and the general public in all areas of medical and human genetics.
The Society works to do that by many approaches, together with instructional periods on the annual convention; coaching programs generally and specialist areas of genetics; an internet useful resource of instructional supplies (EuroGEMS); and a mentorship scheme.
The ESHG Training Committee is implementing new approaches to broaden the attain of its instructional actions and portfolio. With modifications in know-how, appreciation of the utility of genomics in healthcare and the general public’s and sufferers’ elevated consciousness of the function of genomics, this assessment will summarise how the ESHG is adapting to ship progressive instructional exercise.
Illness-associated genetic variants within the regulatory areas of human genes: mechanisms of motion on transcription and genomic assets for dissecting these mechanisms
Entire genome and complete exome sequencing applied sciences play a vital function within the research of the genetic facets of the pathogenesis of assorted ailments. The ample use of genome-wide and exome-wide affiliation research methodology (GWAS and EWAS) made it doable to establish a lot of genetic variants related to ailments.
This info is accrued within the databases like GWAS central, GWAS catalog, OMIM, ClinVar, and so on. A lot of the variants recognized by the GWAS approach are situated within the noncoding areas of the human genome. Based on the ENCODE undertaking, the fraction of areas within the human genome probably concerned in transcriptional management is many instances higher than the fraction of coding areas.
Thus, genetic variation in noncoding areas of the genome can enhance the susceptibility to ailments by disrupting varied regulatory parts (promoters, enhancers, silencers, insulator areas, and so on.). Nevertheless, identification of the mechanisms of affect of pathogenic genetic variants on the ailments threat is tough because of all kinds of regulatory parts.
The current assessment focuses on the molecular genetic mechanisms by which pathogenic genetic variants have an effect on gene expression. On the similar time, consideration is targeting the transcriptional degree of regulation as an preliminary step within the expression of any gene. A triggering occasion mediating the impact of a pathogenic genetic variant on the extent of gene expression could be, for instance, a change within the purposeful exercise of transcription issue binding websites (TFBSs) or DNA methylation change, which, in flip, impacts the purposeful exercise of promoters or enhancers.
Dissecting the regulatory roles of polymorphic loci have been unattainable with out shut integration of contemporary experimental approaches with pc evaluation of a rising wealth of genetic and organic knowledge obtained utilizing omics applied sciences.
The assessment supplies a short description of various probably the most well-known public genomic info assets containing knowledge obtained utilizing omics applied sciences, together with (1) assets that accumulate knowledge on the chromatin states and the areas of transcription issue binding derived from ChIP-seq experiments; (2) assets containing knowledge on genomic loci, for which allele-specific transcription issue binding was revealed primarily based on ChIP-seq know-how; (3) assets containing in silico predicted knowledge on the potential affect of genetic variants on the transcription issue binding websites.
Comparative Evaluation of Genes Related to Weight problems in People Utilizing Bioinformatic Information and Instruments
Weight problems has turn into a severe international drawback that also wants an answer. One of many elements that results in weight problems is genetic predisposition. The id and traits of the genes concerned haven’t but been totally confirmed. Analyzing the genetic contribution to weight problems is a serious step in the direction of the answer. On this in silico research, utilizing on-line bioinformatics instruments, we consider the function of 4 genes which are believed to contribute to weight problems.
Information have been collected and analyzed for the sequences of 4 so-called weight problems genes: FTO (fats mass and obesity-associated protein), PPARG (peroxisome proliferator activated receptor γ), ADRB3 (adrenergic receptor β 3) and FABP2 (fatty acid binding protein 2). Within the first a part of the analysis, details about the genes was collected and arranged and knowledge in FASTA, format are extracted from the Nationwide Middle for Biotechnology Info (NCBI). Within the second half, all genes have been analyzed by evaluating three species of organisms, Homo sapiens (human), Mus musculus (mouse) and Gallus (rooster).
Recombinant Hepatitis C virus Genome polyprotein |
|||
| MBS7037961-5x01mg | MyBiosource | 5x0.1mg | EUR 11785 |
Recombinant Hepatitis C virus Genome polyprotein |
|||
| MBS7037962-002mg | MyBiosource | 0.02mg | EUR 1400 |
Recombinant Hepatitis C virus Genome polyprotein |
|||
| MBS7037962-01mg | MyBiosource | 0.1mg | EUR 2365 |
Recombinant Hepatitis C virus Genome polyprotein |
|||
| MBS7037962-5x01mg | MyBiosource | 5x0.1mg | EUR 10600 |
Hepatitis C virus genotype 1a Genome polyprotein |
|||
| 1-CSB-EP333180HFD | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in E.coli |
|||
Hepatitis C virus genotype 1a Genome polyprotein |
|||
| 1-CSB-MP333180HFD | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in Mammalian cell |
|||
Hepatitis C virus genotype 1b Genome polyprotein |
|||
| 1-CSB-YP530838HVQ(A3) | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
|||
Hepatitis C virus genotype 1b Genome polyprotein |
|||
| 1-CSB-YP530838HVQ(A4) | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
|||
Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|||
| MBS1163442-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1130 |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|||
| MBS1163442-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 875 |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|||
| MBS1163442-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 1010 |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|||
| MBS1163442-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1130 |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein |
|||
| MBS1163442-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1245 |
Recombinant Hepatitis C virus Genome polyprotein,partial |
|||
| AP72393 | SAB | each | Ask for price |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS1087197-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1200 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS1087197-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 1710 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS1197403-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1200 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS1197403-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 1710 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS1041882-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS1018847-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1200 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS1018847-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 1710 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS1017822-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1200 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS1017822-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 1710 |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS7083727-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS7060004-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS7060367-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus Genome polyprotein, partial |
|||
| MBS7060967-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IIA Genome polyprotein |
|||
| MBS1279215-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|||
| MBS1044911-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 870 |
Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|||
| MBS1044911-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 480 |
Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|||
| MBS1044911-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 700 |
Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|||
| MBS1044911-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 625 |
Recombinant Simian hepatitis A virus genotype VI Genome polyprotein |
|||
| MBS1044911-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 690 |
Recombinant Simian hepatitis A virus genotype V Genome polyprotein |
|||
| MBS1013869-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|||
| MBS1431010-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1080 |
Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|||
| MBS1431010-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 755 |
Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|||
| MBS1431010-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 915 |
Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|||
| MBS1431010-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1010 |
Recombinant Human hepatitis A virus genotype IIIA Genome polyprotein |
|||
| MBS1431010-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1110 |
Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|||
| MBS1079380-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1085 |
Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|||
| MBS1079380-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 675 |
Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|||
| MBS1079380-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 840 |
Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|||
| MBS1079380-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 790 |
Recombinant Hepatitis C virus genotype 4a Genome polyprotein |
|||
| MBS1079380-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 980 |
Recombinant Hepatitis GB virus B Genome polyprotein, partial |
|||
| MBS7085832-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IB Genome polyprotein, partial |
|||
| MBS1220473-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein, partial |
|||
| MBS1207515-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IIB Genome polyprotein, partial |
|||
| MBS1307563-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein, partial |
|||
| MBS1255162-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein, partial |
|||
| MBS1251717-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IB Genome polyprotein, partial |
|||
| MBS1057291-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Simian hepatitis A virus genotype IV Genome polyprotein, partial |
|||
| MBS1031233-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IA Genome polyprotein, partial |
|||
| MBS1479676-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Human hepatitis A virus genotype IIIB Genome polyprotein, partial |
|||
| MBS1010551-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| CSB-EP333180HFD | Cusabio | 3004 mg | Ask for price |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| CSB-EP333180HFD-20ug | Cusabio | 20ug | Ask for price |
|
Description: 192-325aa |
|||
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| CSB-MP333180HFD | Cusabio | 4998 mg | Ask for price |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| CSB-MP333180HFD-20ug | Cusabio | 20ug | Ask for price |
|
Description: 192-325aa |
|||
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| CSB-YP530838HVQ(A3) | Cusabio | 6465 mg | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| CSB-YP530838HVQ(A3)-20ug | Cusabio | 20ug | Ask for price |
|
Description: 2-177aa |
|||
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| CSB-YP530838HVQ(A4) | Cusabio | 6466 mg | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| CSB-YP530838HVQ(A4)-20ug | Cusabio | 20ug | Ask for price |
|
Description: 192-358aa |
|||
Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial |
|||
| AP73727 | SAB | each | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial |
|||
| AP73728 | SAB | each | Ask for price |
Recombinant Hepatitis C virus genotype 6d Genome polyprotein, partial |
|||
| MBS1226183-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 6d Genome polyprotein, partial |
|||
| MBS1226183-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 6h Genome polyprotein, partial |
|||
| MBS1239793-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 6h Genome polyprotein, partial |
|||
| MBS1239793-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS1238854-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS1238854-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| MBS1169939-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| MBS1169939-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 2a Genome polyprotein, partial |
|||
| MBS1185658-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 2a Genome polyprotein, partial |
|||
| MBS1185658-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 6b Genome polyprotein, partial |
|||
| MBS1161053-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 6b Genome polyprotein, partial |
|||
| MBS1161053-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS1134475-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS1081858-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS1081858-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 6a Genome polyprotein, partial |
|||
| MBS1111818-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 6a Genome polyprotein, partial |
|||
| MBS1111818-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS1261568-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS1261568-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 2b Genome polyprotein, partial |
|||
| MBS1066487-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 2b Genome polyprotein, partial |
|||
| MBS1066487-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 6k Genome polyprotein, partial |
|||
| MBS1072352-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 6k Genome polyprotein, partial |
|||
| MBS1072352-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS1004937-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS1004937-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| MBS1005431-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 375 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| MBS1005431-002mgMammalianCell | MyBiosource | 0.02mg(Mammalian-Cell) | EUR 425 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| MBS1005431-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 635 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| MBS1005431-01mgMammalianCell | MyBiosource | 0.1mg(Mammalian-Cell) | EUR 1015 |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
| MBS1005431-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1925 |
Recombinant Hepatitis C virus genotype 5a Genome polyprotein, partial |
|||
| MBS1027168-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 5a Genome polyprotein, partial |
|||
| MBS1027168-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 5a Genome polyprotein, partial |
|||
| MBS1001699-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 2505 |
Recombinant Hepatitis C virus genotype 5a Genome polyprotein, partial |
|||
| MBS1001699-1mgYeast | MyBiosource | 1mg(Yeast) | EUR 2980 |
Recombinant Hepatitis C virus genotype 3a Genome polyprotein, partial |
|||
| MBS7091930-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 3a Genome polyprotein, partial |
|||
| MBS7091931-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 2c Genome polyprotein, partial |
|||
| MBS7085011-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 6g Genome polyprotein, partial |
|||
| MBS7085811-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 3k Genome polyprotein, partial |
|||
| MBS7086666-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 6a Genome polyprotein, partial |
|||
| MBS7081854-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 1c Genome polyprotein, partial |
|||
| MBS7090883-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 3b Genome polyprotein, partial |
|||
| MBS7091092-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS7097404-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 2a Genome polyprotein, partial |
|||
| MBS7097910-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS7102489-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 2k Genome polyprotein, partial |
|||
| MBS7099413-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 1c Genome polyprotein, partial |
|||
| MBS7094099-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 2b Genome polyprotein, partial |
|||
| MBS7099644-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS9423307-002mg | MyBiosource | 0.02mg | EUR 505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS9423307-01mg | MyBiosource | 0.1mg | EUR 895 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS9423307-05mg | MyBiosource | 0.5mg | EUR 1975 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS9423307-5x05mg | MyBiosource | 5x0.5mg | EUR 8735 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS9423308-002mg | MyBiosource | 0.02mg | EUR 505 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS9423308-01mg | MyBiosource | 0.1mg | EUR 895 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS9423308-05mg | MyBiosource | 0.5mg | EUR 1975 |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
| MBS9423308-5x05mg | MyBiosource | 5x0.5mg | EUR 8735 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein |
|||
| MBS9420854-002mg | MyBiosource | 0.02mg | EUR 460 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein |
|||
| MBS9420854-01mg | MyBiosource | 0.1mg | EUR 795 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein |
|||
| MBS9420854-1mg | MyBiosource | 1mg | EUR 2525 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein |
|||
| MBS9420854-5x1mg | MyBiosource | 5x1mg | EUR 11205 |
Duck hepatitis A virus polyprotein Polyclonal Antibody |
|||
| MBS9237550-01mL | MyBiosource | 0.1mL | EUR 415 |
Duck hepatitis A virus polyprotein Polyclonal Antibody |
|||
| MBS9237550-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
Hepatitis C Genome polyprotein |
|||
| 1-CSB-RP184674Ba | Cusabio |
|
|
|
Description: Recombinant Hepatitis C Genome polyprotein expressed in E.coli |
|||
Recombinant Hepatitis C virus H77 Genome polyprotein protein, C-His Tag |
|||
| MBS156843-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Hepatitis C virus H77 Genome polyprotein protein, C-His Tag |
|||
| MBS156843-01mg | MyBiosource | 0.1mg | EUR 450 |
Recombinant Hepatitis C virus H77 Genome polyprotein protein, C-His Tag |
|||
| MBS156843-5x01mg | MyBiosource | 5x0.1mg | EUR 1710 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|||
| MBS969708-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 420 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|||
| MBS969708-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 695 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|||
| MBS969708-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1505 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|||
| MBS969708-5x05mgYeast | MyBiosource | 5x0.5mg(Yeast) | EUR 6565 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|||
| MBS969709-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 420 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|||
| MBS969709-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 695 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|||
| MBS969709-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1505 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) (HCV) Genome polyprotein |
|||
| MBS969709-5x05mgYeast | MyBiosource | 5x0.5mg(Yeast) | EUR 6565 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein(E1),partial |
|||
| AP70969 | SAB | 1mg | EUR 2826 |
Recombinant Hepatitis C Genome polyprotein |
|||
| CSB-RP184674Ba | Cusabio | 5430 mg | Ask for price |
Recombinant Hepatitis C Genome polyprotein |
|||
| CSB-RP184674Ba-20ug | Cusabio | 20ug | Ask for price |
|
Description: 1-631aa |
|||
Recombinant Hepatitis C Genome polyprotein |
|||
| RPC24458-100ug | Biomatik Corporation | 100ug | EUR 721.6 |
Recombinant Hepatitis C Genome polyprotein |
|||
| RPC24458-20ug | Biomatik Corporation | 20ug | EUR 448.1 |
Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1) |
|||
| 1-CSB-EP327230HGE | Cusabio |
|
|
|
Description: Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1(ORF1),partial expressed in E.coli |
|||
Recombinant Hepatitis C virus polyprotein |
|||
| MBS1265554-002mg | MyBiosource | 0.02mg | EUR 375 |
Recombinant Hepatitis C virus polyprotein |
|||
| MBS1265554-01mg | MyBiosource | 0.1mg | EUR 635 |
Recombinant Hepatitis C virus polyprotein |
|||
| MBS1265554-5x01mg | MyBiosource | 5x0.1mg | EUR 2630 |
Recombinant Hepatitis C virus polyprotein |
|||
| MBS9422143-001mg | MyBiosource | 0.01mg | EUR 370 |
Recombinant Hepatitis C virus polyprotein |
|||
| MBS9422143-01mg | MyBiosource | 0.1mg | EUR 795 |
Recombinant Hepatitis C virus polyprotein |
|||
| MBS9422143-5x01mg | MyBiosource | 5x0.1mg | EUR 3435 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 |
|||
| MBS1033628-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 375 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 |
|||
| MBS1033628-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 635 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 |
|||
| MBS1033628-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1925 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 |
|||
| MBS1033628-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 8405 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 |
|||
| MBS9420921-002mg | MyBiosource | 0.02mg | EUR 460 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 |
|||
| MBS9420921-01mg | MyBiosource | 0.1mg | EUR 795 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 |
|||
| MBS9420921-1mg | MyBiosource | 1mg | EUR 2525 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 |
|||
| MBS9420921-5x1mg | MyBiosource | 5x1mg | EUR 11205 |
Anti-Hepatitis C virus/HCV Genome polyprotein Nanobody |
|||
| MBS1568320-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Hepatitis C virus/HCV Genome polyprotein Nanobody |
|||
| MBS1568320-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1) |
|||
| AP71039 | SAB | 1mg | EUR 2826 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-1mg |
|||
| QP6996-1mg | EnQuireBio | 1mg | EUR 3037.2 |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1), partial |
|||
| CSB-EP327230HGE | Cusabio | 2937 mg | Ask for price |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1), partial |
|||
| CSB-EP327230HGE-20ug | Cusabio | 20ug | Ask for price |
|
Description: 60-240aa |
|||
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1), partial |
|||
| MBS1135179-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1), partial |
|||
| MBS1308592-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Within the third a part of this research, phylogenetic bushes have been constructed for every of the 4 genes, utilizing blast native alignment search software (BLAST) and molecular evolutionary genetics evaluation (MEGA X) software program. Our evaluation reveals that the capabilities of all these genes are related to obese and weight problems.
